Clinical Trial Update: A Trial of HRS-5965 Capsule in Primary IgA Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 trial of HRS-5965 Capsule for IgA nephropathy is currently recruiting. Sponsor: Chengdu Suncadia Medicine Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• HRS-5965 Capsule

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Primary IgA Nephropathy | Phase 3 | Status: RECRUITING